Andrew D Sklawer - Net Worth and Insider Trading
Andrew D Sklawer Net Worth
The estimated net worth of Andrew D Sklawer is at least $2,049 dollars as of 2024-11-13. Andrew D Sklawer is the COO and Secretary of Fresh Tracks Therapeutics Inc and owns about 2,769 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $2,049. Details can be seen in Andrew D Sklawer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew D Sklawer has not made any transactions after 2021-05-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew D Sklawer
Andrew D Sklawer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew D Sklawer owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .
Click here to see the complete history of Andrew D Sklawer’s form 4 insider trades.
Insider Ownership Summary of Andrew D Sklawer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-06-14 | COO and Secretary |
Andrew D Sklawer Latest Holdings Summary
Andrew D Sklawer currently owns a total of 1 stock. Andrew D Sklawer owns 2,769 shares of Fresh Tracks Therapeutics Inc (FRTX) as of May 17, 2021, with a value of $2,049.
Latest Holdings of Andrew D Sklawer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-05-17 | 2,769 | 0.74 | 2,049 |
Holding Weightings of Andrew D Sklawer
Andrew D Sklawer Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew D Sklawer has made a total of 1 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 342 shares on May 17, 2021, which cost Andrew D Sklawer around $12,300.
Insider Trading History of Andrew D Sklawer
- 1
Andrew D Sklawer Trading Performance
GuruFocus tracks the stock performance after each of Andrew D Sklawer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew D Sklawer is -22.96%. GuruFocus also compares Andrew D Sklawer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew D Sklawer within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew D Sklawer's insider trading performs compared to the benchmark.
Performance of Andrew D Sklawer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.37 | | | | | |
| Relative Return to S&P 500(%) | 5.96 | | | | | |
Andrew D Sklawer Ownership Network
Ownership Network List of Andrew D Sklawer
Ownership Network Relation of Andrew D Sklawer
Andrew D Sklawer Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Andrew D Sklawer is the COO and Secretary of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Andrew D Sklawer made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Andrew D Sklawer Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew D Sklawer. You might contact Andrew D Sklawer via mailing address: 5777 Central Avenue, Suite 102, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
